The Single Best Strategy To Use For Ago tumor
Molecular typing relies on molecular genetic tests and is not still routinely accessible. Molecular subtypes and immunohistochemical surrogate markers of the tumors (HR, HER2, triple destructive) correlate in about 70%. The differentiation of luminal A and B subtypes by HR status and proliferation markers like Ki-sixty seven may very well be valuab